Back to results
US 2019/0194282 A1Published application
CHIMERIC PROTEINS FOR TARGETING dsRNA
AssigneeTargimmune Therapeutics AG
InventorsAlexander LEVITZKI, Yael LANGUT
Life of this patent
Estimating the term…
Abstract
Described herein are recombinant chimeric proteins comprising a double stranded RNA (dsRNA) binding domain and a cancer-cell targeting domain for targeting of dsRNA to cancer cells. Methods of use of the described chimeric proteins are also provided herein.
Claims18
A chimeric recombinant protein comprising:
- a double stranded RNA (dsRNA) binding domain;
- and
- a target binding moiety that binds to prostate surface membrane antigen (PSMA).
Dependencies are inferred from the claim text.